These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 8322763)

  • 1. Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile.
    Levine OS; Ortiz E; Contreras R; Lagos R; Vial P; Misraji A; Ferreccio C; Espinoza C; Adlerstein L; Herrera P
    Am J Epidemiol; 1993 Jun; 137(11):1221-8. PubMed ID: 8322763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants.
    Mulholland K; Hilton S; Adegbola R; Usen S; Oparaugo A; Omosigho C; Weber M; Palmer A; Schneider G; Jobe K; Lahai G; Jaffar S; Secka O; Lin K; Ethevenaux C; Greenwood B
    Lancet; 1997 Apr; 349(9060):1191-7. PubMed ID: 9130939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections.
    Lagos R; Horwitz I; Toro J; San Martin O; Abrego P; Bustamante C; Wasserman SS; Levine OS; Levine MM
    Pediatr Infect Dis J; 1996 Mar; 15(3):216-22. PubMed ID: 8852909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation.
    Platonov AE; Griffiths UK; Voeykova MV; Platonova OV; Shakhanina IL; Chistyakova GG; Robertson SE;
    Vaccine; 2006 Mar; 24(13):2367-76. PubMed ID: 16413949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccination in India.
    Clark AD; Griffiths UK; Abbas SS; Rao KD; Privor-Dumm L; Hajjeh R; Johnson H; Sanderson C; Santosham M
    J Pediatr; 2013 Jul; 163(1 Suppl):S60-72. PubMed ID: 23773596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of the Haemophilus influenzae type b vaccine for infants in mainland China.
    Ning G; Yin Z; Li Y; Wang H; Yang W
    Hum Vaccin Immunother; 2018 Jan; 14(1):36-44. PubMed ID: 29049002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The introduction of routine Haemophilus influenzae type b conjugate vaccine in Chile: a framework for evaluating new vaccines in newly industrializing countries.
    Lagos R; Levine OS; Avendaño A; Horwitz I; Levine MM
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S139-48. PubMed ID: 9781748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
    Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
    Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of Haemophilus influenzae type b disease in Australia and an economic appraisal of the vaccine PRP-OMP.
    Harris A; Hendrie D; Bower C; Payne J; de Klerk N; Stanley F
    Med J Aust; 1994 Apr; 160(8):483-8. PubMed ID: 8170423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial.
    Gessner BD; Sutanto A; Linehan M; Djelantik IG; Fletcher T; Gerudug IK; Ingerani ; Mercer D; Moniaga V; Moulton LH; Moulton LH; Mulholland K; Nelson C; Soemohardjo S; Steinhoff M; Widjaya A; Stoeckel P; Maynard J; Arjoso S
    Lancet; 2005 Jan 1-7; 365(9453):43-52. PubMed ID: 15643700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in low- and middle-income countries: regional analysis and assessment of major determinants.
    Griffiths UK; Clark A; Hajjeh R
    J Pediatr; 2013 Jul; 163(1 Suppl):S50-S59.e9. PubMed ID: 23773595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.
    Gessner BD; Sedyaningsih ER; Griffiths UK; Sutanto A; Linehan M; Mercer D; Mulholland EK; Walker DG; Steinhoff M; Nadjib M
    Pediatr Infect Dis J; 2008 May; 27(5):438-43. PubMed ID: 18398383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens.
    Lagos R; Valenzuela MT; Levine OS; Losonsky GA; Erazo A; Wasserman SS; Levine MM
    Lancet; 1998 May; 351(9114):1472-6. PubMed ID: 9605803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. World-wide strategies for immunization against invasive Haemophilus influenzae type b disease.
    Iwarson S
    Vaccine; 1993; 11 Suppl 1():S28-9. PubMed ID: 8447169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumonia Prevention during a Humanitarian Emergency: Cost-effectiveness of Haemophilus Influenzae Type B Conjugate Vaccine and Pneumococcal Conjugate Vaccine in Somalia.
    Gargano LM; Hajjeh R; Cookson ST
    Prehosp Disaster Med; 2015 Aug; 30(4):402-11. PubMed ID: 26061190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemophilus influenzae type b meningitis in The Gambia after introduction of a conjugate vaccine.
    Adegbola RA; Usen SO; Weber M; Lloyd-Evans N; Jobe K; Mulholland K; McAdam KP; Greenwood BM; Milligan PJ
    Lancet; 1999 Sep; 354(9184):1091-2. PubMed ID: 10509502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The cost-effectiveness of Haemophilus influenzae type b vaccine for children under 2 years of age in Colombia].
    Alvis Guzmán N; De La Hoz Restrepo F; Vivas Consuelo D
    Rev Panam Salud Publica; 2006 Oct; 20(4):248-55. PubMed ID: 17316483
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Slack M; Esposito S; Haas H; Mihalyi A; Nissen M; Mukherjee P; Harrington L
    Expert Rev Vaccines; 2020 Oct; 19(10):903-917. PubMed ID: 32962476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of the value of Haemophilus influenzae type b conjugate vaccine in Asia.
    Miller MA
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S152-9. PubMed ID: 9781750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The retreat of Hemophilus influenzae type B invasive disease: analysis of an immunization program and implications for OTO-HNS.
    Beck RA; Kambiss S; Bass JW
    Otolaryngol Head Neck Surg; 1993 Oct; 109(4):712-21. PubMed ID: 8233509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.